Cancer Research CTRC-AACR San Antonio Breast Cancer Symposium  Tumor Immunology: New Perspectives
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online

[Cancer Research 27, 490-497, March 1, 1967]
© 1967 American Association for Cancer Research

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Magnus, E. M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Magnus, E. M.

Folate Activity in Serum and Red Cells of Patients with Cancer

Erik M. Magnus

Oslo City Hospital, Krohgstötten Department, Oslo, Norway

The serum and red cell folic acid activity (FAA) values were within normal limits in patients with localized cancer. In 85% of a series of patients having metastatic cancer the serum folate was found to be abnormally low although the red cell folate remained normal.

Among 26 patients with cancer originating in the liver, the pancreas, the gall bladder, or the biliary ducts, the serum and red cell FAA values were somewhat more variable. Released folate from damaged liver cells may be a contributing factor to higher serum and red cell FAA values in several of these cases.

Anemia developing in cancer patients may be due partly to folic acid deficiency as indicated by reduced serum FAA, even in the presence of a red cell FAA within normal limits, presumably because of increased folate utilization by tumor.

Received 6/21/65. Accepted 10/20/66.




This article has been cited by other articles:


Home page
BloodHome page
R. F. Branda, E. Nigels, A. R. Lafayette, and M. Hacker
Nutritional Folate Status Influences the Efficacy and Toxicity of Chemotherapy in Rats
Blood, October 1, 1998; 92(7): 2471 - 2476.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 1967 by the American Association for Cancer Research.